36 filings
Page 2 of 2
8-K
umozpd2qf
17 Jun 22
Amendments to Articles of Incorporation or Bylaws
7:52pm
8-K
11hn966xauch21
27 May 22
Submission of Matters to a Vote of Security Holders
5:24pm
8-K
gknfitbo
12 May 22
4D Molecular Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates
4:32pm
8-K
l3kwmk mk3jiw7hfay
28 Mar 22
4D Molecular Therapeutics Reports Full Year 2021 Financial Results and Operational Highlights
4:38pm
8-K
xmemid4n9sn7
22 Feb 22
Departure of Directors or Certain Officers
4:45pm
8-K
8x5z9
11 Jan 22
Regulation FD Disclosure
7:01am
8-K
zbw3i2
10 Nov 21
4D Molecular Therapeutics Reports Financial Results for the Third Quarter of 2021 and Provides Operational Highlights
4:20pm
8-K
4mb k5u5m
26 Oct 21
Other Events
6:30am
8-K
if1wdwkw
13 Oct 21
Other Events
4:37pm
8-K
ope0b yan2lqr
24 Sep 21
Departure of Directors or Certain Officers
4:59pm
8-K
60mta3qi1np9
12 Aug 21
4D Molecular Therapeutics Reports Financial Results for the Second Quarter of 2021 and Provides Operational Highlights
4:16pm
8-K
73fvfwuylpicxp201u3h
25 Jun 21
Termination of a Material Definitive Agreement
4:01pm
8-K
b3h5 uteiy6pu
20 May 21
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
en3k a3fpk
13 May 21
4D Molecular Therapeutics Reports Financial Results for the First Quarter of 2021 and Provides Operational Highlights
4:15pm
8-K
ido ds76dugnm
25 Mar 21
Results of Operations and Financial Condition
4:11pm
8-K
y61d9
15 Dec 20
Amendments to Articles of Incorporation or Bylaws
5:01pm